Hydrochlorothiazide

Product NDC: 67046-378
11-digit product format: 670460378
Labeler code: 67046
Product ID: 67046-378_bc1a6c75-2ef0-1566-e053-2995a90aab9f
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Hydrochlorothiazide
Dosage form: TABLET
Route: ORAL
Labeler: Contract Pharmacy Services-PA
Application: ANDA202556
Marketing category: ANDA
Marketing start: 2021-02-12
Marketing end: 0000-00-00
Substance: HYDROCHLOROTHIAZIDE
Active strength: 13 mg/1
Pharmacologic classes: Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
67046-378-30	2024-11-08	C162847	48780-1	f386c64a-27a7-0266-e053-dadaa90a7c1a	HYDROCHLOROTHIAZIDE TABLETS, USP 12.5 mg, 25 mg and 50 mg Rx only
67046-378-30	2023-01-30	C162847	48780-1	f386c64a-27a7-0266-e053-dadaa90a7c1a	HYDROCHLOROTHIAZIDE TABLETS, USP 12.5 mg, 25 mg and 50 mg Rx only

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
0J48LPH2TH	HYDROCHLOROTHIAZIDE	58-93-5	HYDROCHLOROTHIAZIDE

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
67046-378-30	67046037830	30 TABLET in 1 BLISTER PACK (67046-378-30)	30 tablet	2021-02-12	0000-00-00	No	No	Current